Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase II IMvigor210 study

Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase II IMvigor210 study / Necchi, A., Joseph, R.w., Loriot, Y., Hoffman-Censits, J., Perez-Gracia, J.l., Petrylak, D.p., Derleth, C.l., Tayama, D., Zhu, Q., Ding, B., Kaiser, C., Rosenberg, J.e.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 28:12(2017), pp. 3044-3050. [10.1093/annonc/mdx518]